28
Oct
2025

BDR PHARMACEUTICALS INTERNATIONAL PVT.

Exhibitor at CPHI Frankfurt 2025 stand 9.1C94, Integrated Pharma
About Us

BDR – A renowned name in the global pharmaceutical industry recognized for its Niche Molecules, Quality Products and for providing Affordable and Accessible Healthcare solutions.

BDR Group draws its expertise and reputation as a niche and innovative company by focusing its strategy on identifying prevailing therapeutic gaps, developing generic alternatives for various diseases currently affecting people. We also focus on addressing future diseases and ailments by adopting modern techn...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 9.1C94, Integrated Pharma

Products Featured at CPHI Frankfurt 2025

  • [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]

    Product [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]. It belongs to ranolazine intermediates products category. Contact us for more information.
  • [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]

    Product [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]. It belongs to risedronate sodium intermediates products category. Contact us for more information.
  • [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]

    Product [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]. It belongs to irbesartan intermediates products category. Contact us for more informat...
  • [138401-24-8]

    Product [138401-24-8]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [138401-24-8]. It belongs to irbesartan intermediates products category. Contact us for more information.
  • 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]

    Product 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]. It belongs to ranolazine intermediates products category. Contact us for more information.
  • 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]

    Product 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]. It belongs to ranolazine intermediates products category. Contact us for more information.
  • 2- thiazine-1,1-dioxide. Cas no : 70417-50-8

    Product 2- thiazine-1,1-dioxide. Cas no : 70417-50-8

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2- thiazine-1,1-dioxide. Cas no : 70417-50-8. It belongs to lornoxicam intermediates products category. Contact us for more information.
  • 2-(1-adamantyl)-4-bromophenol 2-(1-adamantyl) -4-bromoanisole [104224-63-7]

    Product 2-(1-adamantyl)-4-bromophenol 2-(1-adamantyl) -4-bromoanisole [104224-63-7]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-(1-adamantyl)-4-bromophenol 2-(1-adamantyl) -4-bromoanisole [104224-63-7]. It belongs to adapalene intermediates products category. Contact us for more information.
  • 2-chloro-1, 3-bis (dimethylamino)-trimethinium hexafluorophosphate

    Product 2-chloro-1, 3-bis (dimethylamino)-trimethinium hexafluorophosphate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-chloro-1, 3-bis (dimethylamino)-trimethinium hexafluorophosphate. It belongs to etoricoxib intermediates products category. Contact us for more information.
  • 2-n butyl-3-[(2-cyanobiphenyl-4-yl) methyl]-1,3-diazaspiro [4,4] non-1-en-4-one

    Product 2-n butyl-3-[(2-cyanobiphenyl-4-yl) methyl]-1,3-diazaspiro [4,4] non-1-en-4-one

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n butyl-3-[(2-cyanobiphenyl-4-yl) methyl]-1,3-diazaspiro [4,4] non-1-en-4-one. It belongs to irbesartan intermediates products category. Contact us for more information.
  • 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]

    Product 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]. It belongs to telmisartan intermediates products category. Contact us for more information.
  • 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole

    Product 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole. It belongs to telmisartan intermediates products category. Contact us for more information.
  • 4-(3-methylphenyl)amino-3-pyridine sulphonamid

    Product 4-(3-methylphenyl)amino-3-pyridine sulphonamid

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-(3-methylphenyl)amino-3-pyridine sulphonamid. It belongs to torsemide intermediates products category. Contact us for more information.
  • 4-(aminomethyl) pyrolidine -3-one-o-methyloxime mesylate

    Product 4-(aminomethyl) pyrolidine -3-one-o-methyloxime mesylate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-(aminomethyl) pyrolidine -3-one-o-methyloxime mesylate. It belongs to gemifloxacin intermediates products category. Contact us for more information.
  • 4-cyanothiomethylbenzyl-3-(6-methyl)-pyridyl ketone

    Product 4-cyanothiomethylbenzyl-3-(6-methyl)-pyridyl ketone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-cyanothiomethylbenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.
  • 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone

    Product 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.
  • 4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone

    Product 4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.
  • 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1

    Product 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1. It belongs to lornoxicam intermediates products category. Contact us for more information.
  • 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]

    Product 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.
  • 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]

    Product 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.
  • 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]

    Product 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]. It belongs to gemifloxacin intermediates products category. Contact us for more inf...
  • Abacavir sulphate

    Product Abacavir sulphate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abacavir sulphate. It belongs to antiretroviral apis category. Contact us for more information.
  • Abiraterone

    Product Abiraterone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abiraterone. It belongs to anticancer apis category. Contact us for more information.
  • Aceclofenac

    Product Aceclofenac

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac. It belongs to antiinflammatory ( nsaid ) apis category. Contact us for more information.
  • Aceclofenac injections 150 mg

    Product Aceclofenac injections 150 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac injections 150 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.
  • Aceclofenac sustained release tablets 200 mg

    Product Aceclofenac sustained release tablets 200 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac sustained release tablets 200 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.
  • Aceclofenac tablets 100 mg

    Product Aceclofenac tablets 100 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac tablets 100 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.
  • Acyclovir

    Product Acyclovir

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes acyclovir. It belongs to lypholised powder ready to fill category. Contact us for more information.
  • Adapalene

    Product Adapalene

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adapalene. It belongs to antiacne apis category. Contact us for more information.
  • Adapalene and clindamycin gel (0.1 + 1) % w/w

    Product Adapalene and clindamycin gel (0.1 + 1) % w/w

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adapalene and clindamycin gel (0.1 + 1) % w/w. It belobgs to dermotology finish formulations products category. Contact us for more information.
  • Adefovir

    Product Adefovir

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adefovir. It belongs to antiretroviral apis category. Contact us for more information.
  • Agomelatine

    Product Agomelatine

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes agomelatine. It belongs to antideperessant apis category. Contact us for more information.
  • Alendronate sodium

    Product Alendronate sodium

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes alendronate sodium. It belongs to antiosteoporosis apis category. Contact us for more information.
  • Alfacalcidol

    Product Alfacalcidol

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes alfacalcidol. It belongs to antiosteoporosis apis category. Contact us for more information.
  • Alfuzosin hcl

    Product Alfuzosin hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes alfuzosin hcl. It belongs to treating benign prostatic hyperplasia ( bph ) apis category. Contact us for more information.
  • Amphotericin b (liposomal) for injection 50 mg

    Product Amphotericin b (liposomal) for injection 50 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes amphotericin b (liposomal) for injection 50 mg. It belongs to antifungal finish formulations products category. Contact us for more information.
  • Anastrazole

    Product Anastrazole

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes anastrazole. It belongs to antineoplastic apis category. Contact us for more information.
  • Anastrazole 1mg tabs

    Product Anastrazole 1mg tabs

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes anastrazole 1mg tabs. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Aprepitant

    Product Aprepitant

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aprepitant. It belongs to antiemetic apis category. Contact us for more information.
  • Aripiprazole

    Product Aripiprazole

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aripiprazole. It belongs to antideperessant apis category. Contact us for more information.
  • Asenapine 5/10 mg- under development

    Product Asenapine 5/10 mg- under development

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes asenapine 5/10 mg- under development. It belongs to central nervous system finish formulations products category. Contact us for more information.
  • Asenapine maleate

    Product Asenapine maleate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes asenapine maleate. It belongs to antipsycotic apis category. Contact us for more information.
  • Atomoxetine hcl

    Product Atomoxetine hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes atomoxetine hcl. It belongs to antideperessant apis category. Contact us for more information.
  • Atorvastatin calcium (crystalline & amorphous)

    Product Atorvastatin calcium (crystalline & amorphous)

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes atorvastatin calcium (crystalline & amorphous). It belongs to antihyperlipidemic apis category. Contact us for more information.
  • Azathioprine

    Product Azathioprine

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes azathioprine. It belongs to immunosuppresant apis category. Contact us for more information.
  • Azithromycin dihydrate

    Product Azithromycin dihydrate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes azithromycin dihydrate. It belongs to lypholised powder ready to fill category. Contact us for more information.
  • Aztreonam + l ? arginine

    Product Aztreonam + l ? arginine

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aztreonam + l ? arginine. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.
  • Balofloxacin

    Product Balofloxacin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes balofloxacin. It belongs to quinolone apis products category. Contact us for more information.
  • Bendamustin hcl

    Product Bendamustin hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustin hcl. It belongs to antineoplastic apis category. Contact us for more information.
  • Bendamustine 100 mg*

    Product Bendamustine 100 mg*

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustine 100 mg*. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
  • Besifloxacin

    Product Besifloxacin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes besifloxacin. It belongs to quinolone apis products category. Contact us for more information.
  • Biapenem 300 mg / 600 mg* --- under development

    Product Biapenem 300 mg / 600 mg* --- under development

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem 300 mg / 600 mg* --- under development. It belobgs to carbapenem finish formulations products category. Contact us for more information.